Use of 5-trans prostaglandin F2 alpha as an ocular hypotensive agent
A Standard patent application filed on 12 February 1991 credited to Woodward, David Frederick

Details

Application number :

74421  

Application type :

Standard  

Application status :

CEASED  

Under opposition :

No  

Proceeding type :

 

Invention title :

Use of 5-trans prostaglandin F2 alpha as an ocular hypotensive agent  

Inventor :

Woodward, David Frederick  

Agent name :

Davies Collison Cave  

Address for service :

Level 15 1 Nicholson Street MELBOURNE VIC 3000  

Filing date :

12 February 1991  

Associated companies :

 

Applicant name :

Allergan, Inc.  

Applicant address :

2525 Dupont Drive Post Office Box 19534 Irvine CA 92713-9534 United States Of America  

Old name :

 

Original Source :

Go  

Same Inventor

• Use of prostaglandin F3 alpha as an ocular hypotensive agent
• Intraocular pressure reducing 11-acyl prostaglandins
• Intraocular pressure reducing 9, 15-diacyl prostaglandins
• Intraocular pressure reducing 11, 15-diacyl prostaglandins
• Use of platelet activating factor antagonists as anti-pruritic agents